Previous study identified TGF-β signaling exhibiting a dual role in CRC by suppressing early tumorigenesis but promoting EMT-driven metastasis in advanced stages through epigenetic dysregulation of its pathway components (30). The gene discussed is TGFB1; the disease is colorectal carcinoma.